Skip to main content
Elsevier

The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics: Part B

  • 1st Edition, Volume 4 - September 1, 2022
  • Latest edition
  • Editors: Marc E. Lavoie, Andrea E. Cavanna
  • Language: English

The Neurobiology of the Gilles de la Tourette Syndrome and Chronic Tics, Part B, Volume Four reviews historical background, current nosology and guidelines. In addition, it includ… Read more

Description

The Neurobiology of the Gilles de la Tourette Syndrome and Chronic Tics, Part B, Volume Four reviews historical background, current nosology and guidelines. In addition, it includes an overview of pathophysiology, ranging from its genetic basis and changes in neurochemistry and electrophysiology to widespread neural circuits. Specific chapters cover The genetic basis of Gilles de la Tourette Syndrome, Genome-wide association study of Tourette Syndrome, De Novo mutations in Tourette Syndrome, Animal models for Tourette Syndrome, The neural-immune crosstalk in Tourette syndrome: from immunobiology to epistemology, Functional connectivity in the Gilles de la Tourette Syndrome, and much more.

Key features

  • Includes examines of Gilles de la Tourette Syndrome at behavioral, cognitive, clinical, electrophysiological, molecular and genetic levels
  • Provides a comprehensive overview of the neurobiological aspects of Gilles de la Tourette Syndrome
  • Edited and authored by top researchers and clinicians treating Gilles de la Tourette Syndrome

Readership

Researchers, Physicians; Psychiatrists, Neurologists; Neuropsychologist; Geneticists; Neuroscientists; Professors in psychiatry and psychology; medical residents

Table of contents

Preface
Marc E. Lavoie and Andrea E. Cavanna

1. The genetic basis of Gilles de la Tourette syndrome
Sarah B. Abdallah, Evan Realbuto, Mary Oluwatosin Kaka, Kelly Yang, Apostolia Topaloudi, Peristera Paschou, Jeremiah M. Scharf and Thomas V. Fernandez

2. Studying the pathophysiology of tic disorders in animal models
Christopher Pittenger

3. The neural-immune crosstalk in Tourette syndrome: From immunobiology to epistemology
Yasamin Mahjoub, Davide Martino and Andrea E. Cavanna

4. Functional connectivity in the Gilles de la Tourette syndrome
Matthew Feigelis and Deanna J. Greene

5. Perception-action integration in Gilles de la Tourette syndrome
Theresa Paulus, Christian Beste and Alexander Münchau

6. The pharmacological treatment of Tourette syndrome
José Fidel Baizabal-Carvallo and Joseph Jankovic

7. Ecopipam: A D1 receptor antagonist for the treatment of Tourette syndrome
Richard E. Chipkin, Donald L. Gilbert and Atul Mahableshwarkar

8. Atypical antipsychotics for treatment of Tourette syndrome
Vamsi K. Kalari, Peter E. Morrison and Cathy L. Budman

9. Alpha agonists for the treatment of Tourette syndrome
Nick Cothros and Tamara Pringsheim

10. Cannabinoids: Possible role in the pathophysiology and therapy of Gilles de la Tourette syndrome
Natalia Szejko and Kirsten Müller-Vahl

11. Novel potential avenues for the therapy of Tourette syndrome: Cannabinoid and steroid-based tools
Marco Bortolato and Roberto Cadeddu

12. Non-invasive brain stimulation for the treatment of Tourette's syndrome
Sneha Chenji, Kayla D. Stone and Frank P. MacMaster

13. Entrainment of movement-related brain oscillations to improve symptoms in Tourette syndrome
Mairi Houlgreave, Bàrbara Morera Maiquez, Katherine Dyke, Georgina Jackson and Stephen Jackson

14. Network oscillatory activity in chronic tics and Tourette syndrome
Joohi Jimenez-Shahed

Product details

  • Edition: 1
  • Latest edition
  • Volume: 4
  • Published: September 3, 2022
  • Language: English

About the editors

ML

Marc E. Lavoie

Marc E. Lavoie, PhD is currently research professor of Psychiatry and Neuroscience at the University of Montréal, and since 2001 he is directing the Cognitive and Social Psychophysiology Laboratory, at the research center of the Institut Universitaire en Santé Mentale de Montréal (Canada). His research training was completed in the field of psychophysics (Université de Moncton, Canada), experimental neuropsychology (Université de Montréal, Canada), developmental psychology (Universiteit van Amsterdam, the Nederland) and in psychobiology (Université de Lille, France). He directs a clinical research program currently funded by the Canadian Institutes of Health Research that addresses crucial issues about the relationship between brain functions, behavior, and cognition in various neurodevelopmental and habit disorders, primarily in Tourette’s syndrome and behavior-focused repetitive behavior.
Affiliations and expertise
Centre de Recherche de l’Institut Universitaire en Sante Mentale de Montreal, Departement de Psychiatrie et Addictologie, Universite de Montreal, Quebec, Canada

AC

Andrea E. Cavanna

Andrea E. Cavanna, MD, PhD, FRCP, FANPA, SFHEA, works as a clinician (Consultant in Behavioural Neurology at the Department of Neuropsychiatry, National Centre for Mental Health, Birmingham, UK) and as an academic (Honorary Professor in Neuropsychiatry at Aston University, Birmingham, UK). His medical training was completed in Italy (University of Turin and A. Avogadro University, Novara) and in the United Kingdom (University College London). Since 2008 he has been Lead Consultant for the specialist Tourette syndrome clinic. His research activity focuses on the behavioural aspects of neurological conditions. He coordinates training activities directed at the future generation of clinical scientists by running the Tourette syndrome module of the MSc in Clinical Neuropsychiatry at the University of Birmingham.
Affiliations and expertise
Honorary Professor in Neuropsychiatry at Aston University, Birmingham, UK

View book on ScienceDirect

Read The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics: Part B on ScienceDirect